State and problems of clinical trials in Russian Federation
- Authors: Kuzmin AA1
-
Affiliations:
- Republic Clinical Oncological Center of the Ministry of Health of the Republic of Tatarstan
- Issue: Vol 18, No 5 (2016)
- Pages: 7-9
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/27100
- ID: 27100
Cite item
Full Text
Abstract
The Russian Federation is considered one of the most promising platforms for any phase of clinical trials, the maximum number of which was registered in 2011. The participation in clinical trials is often the only option to get advanced treatment for people, significant budget savings for clinics, and the opportunity to learn to work with new drugs before they enter the practice - for doctors. On average, the number of international clinical trials in our country is 10 times lower than in European countries and the United States, which is associated with a number of problems - legislative, clinical, logistics, diagnostics.
Full Text
##article.viewOnOriginalSite##About the authors
A A Kuzmin
Republic Clinical Oncological Center of the Ministry of Health of the Republic of Tatarstan
Email: al.al.kuzmin@mail.ru
врач-онколог высшей категории, зав. отд-нием химиотерапии №2 ГАУЗ РКОД, рук. направления «Лимфопролиферативные заболевания» 420029, Russian Federation, Kazan, ul. Sibirskiy trakt, d. 29
References
- Clinical Trials in Russia Orange Paper 1st & 2nd Quarter 2016. ©CRO Synergy Research Group. Moscow. www.synergycro.ru.
- VADEMECUM 2016; 14 (125).
- Отчеты FDA.